Insight

Astorg racks up 4bn euros for eighth fund

Astorg VIII's target and hard cap is 4.5 billion euros, a nearly 10 percent increase on its predecessor fund.

-
  • The fund will focus on pan-European B2B companies
  • Astorg VIII’s investments include Pharma, a pharma CDMO; and Open Health, a provider of medical communications and market access services to the pharmaceutical industry
  • Astorg has over 21 billion euros of assets under management

European private equity firm Astorg has raised 4 billion euros for its flagship eighth fund.

Astorg VIII’s target and hard cap is 4.5 billion euros, a nearly 10 percent increase on its predecessor fund.

“This interim closing further illustrates the appeal of Astorg’s investment strategy to major international investors, despite challenging fundraising market conditions, and brings additional diversification of Astorg’s investor base across categories and geographies,” said Jean Raby, head of business development at Astorg. “We also see the early success of Astorg’s enhanced focus on family offices and high net worth individuals worldwide.”

The fund will focus on pan-European B2B companies in four verticals: healthcare, technology, business services and industrials.

So far, Astorg VIII has made a number of investments, which include Pharma, a pharma CDMO; and Open Health, a provider of medical communications and market access services to the pharmaceutical industry.

With offices in London, Paris, New York, Frankfurt, Milan, and Luxembourg, Astorg has over 21 billion euros of assets under management.